Difference between revisions of "Part:BBa K4960029"
Line 12: | Line 12: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
PVC13 is a sequence that can encode the tail fibre as the targeting element of the PVC. [1]The PVC fiber protein Pvc13 contains at least 10 repeated motifs resembling the adenovirus fiber and a gp10/gp12 domain, which is probably derived from T4 short tail fiber[2][3]Therefore, it is tempting to speculate that the Pvc13 is another fusion protein derived from the T4 and adenovirus fibers, which may have enabled its recognition of eukaryotic cells.[4] | PVC13 is a sequence that can encode the tail fibre as the targeting element of the PVC. [1]The PVC fiber protein Pvc13 contains at least 10 repeated motifs resembling the adenovirus fiber and a gp10/gp12 domain, which is probably derived from T4 short tail fiber[2][3]Therefore, it is tempting to speculate that the Pvc13 is another fusion protein derived from the T4 and adenovirus fibers, which may have enabled its recognition of eukaryotic cells.[4] | ||
− | Sequence CKGGRAKDC is a peptide motif that homes to white fat vasculature. | + | Sequence CKGGRAKDC is a peptide motif that homes to white fat vasculature.The in vivo localization studies presented show that CKGGRAKDC targets the white adipose vasculature without a detectable preference for any particular anatomical white fat depot. Meanwhile, the motif is preferentially internalized by a receptor in the adipose vasculature that may serve for targeted delivery of therapeutic compounds to fat.[5] |
The linker 3*EAAAK on both sides of CKGGRAKDC can affect the function and efficiency of bond and recognition by affecting the structure of the tail protein. | The linker 3*EAAAK on both sides of CKGGRAKDC can affect the function and efficiency of bond and recognition by affecting the structure of the tail protein. | ||
<html> | <html> | ||
Line 41: | Line 41: | ||
Figure 3.Horizontal cutaway view of the fiber region of the syringe. | Figure 3.Horizontal cutaway view of the fiber region of the syringe. | ||
===Special Design=== | ===Special Design=== | ||
− | Use the CKGGRAKDC to target fat cells. | + | Use the CKGGRAKDC to target fat cells.<br> |
The different linker(1*EAAAK or 3*EAAAK) on both sides of the CKGGRAKDC can affect the structure and function of the tail protein. By altering the linker on both sides of the CKGGRAKDC, we explored the most suitable structure of the tail protein for recognition and bond. At the same time, because of the existence of linker, we can use Golden Gate to replace the sequences in the middle of linker more efficiently than enzyme cutting and enzyme linking. | The different linker(1*EAAAK or 3*EAAAK) on both sides of the CKGGRAKDC can affect the structure and function of the tail protein. By altering the linker on both sides of the CKGGRAKDC, we explored the most suitable structure of the tail protein for recognition and bond. At the same time, because of the existence of linker, we can use Golden Gate to replace the sequences in the middle of linker more efficiently than enzyme cutting and enzyme linking. | ||
<!-- --> | <!-- --> |
Revision as of 06:20, 12 October 2023
PVC13_NTD-3*EAAAK-CKGGRAKDC-3*EAAAK-PVC13_CTD
A sequence used to encode PVC fiber protein
Profile
Name: PVC13_NTD-3*EAAAK-CKGGRAKDC-3*EAAAK-PVC13_CTD
Base Pairs: 1422bp
Origin: Photorhabdus, Synthetic
Properties: A sequence used to encode PVC fiber protein
Usage and Biology
PVC13 is a sequence that can encode the tail fibre as the targeting element of the PVC. [1]The PVC fiber protein Pvc13 contains at least 10 repeated motifs resembling the adenovirus fiber and a gp10/gp12 domain, which is probably derived from T4 short tail fiber[2][3]Therefore, it is tempting to speculate that the Pvc13 is another fusion protein derived from the T4 and adenovirus fibers, which may have enabled its recognition of eukaryotic cells.[4] Sequence CKGGRAKDC is a peptide motif that homes to white fat vasculature.The in vivo localization studies presented show that CKGGRAKDC targets the white adipose vasculature without a detectable preference for any particular anatomical white fat depot. Meanwhile, the motif is preferentially internalized by a receptor in the adipose vasculature that may serve for targeted delivery of therapeutic compounds to fat.[5] The linker 3*EAAAK on both sides of CKGGRAKDC can affect the function and efficiency of bond and recognition by affecting the structure of the tail protein. Figure 1.Schematic diagram of the influence of different Linkers on the structure of tail fibers Figure 2.PVC illustration Figure 3.Horizontal cutaway view of the fiber region of the syringe.
Special Design
Use the CKGGRAKDC to target fat cells.
The different linker(1*EAAAK or 3*EAAAK) on both sides of the CKGGRAKDC can affect the structure and function of the tail protein. By altering the linker on both sides of the CKGGRAKDC, we explored the most suitable structure of the tail protein for recognition and bond. At the same time, because of the existence of linker, we can use Golden Gate to replace the sequences in the middle of linker more efficiently than enzyme cutting and enzyme linking.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 309
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
References
[1] Kreitz J, Friedrich MJ, Guru A, Lash B, Saito M, Macrae RK, Zhang F. Programmable protein delivery with a bacterial contractile injection system. Nature. 2023 Apr;616(7956):357-364. doi: 10.1038/s41586-023-05870-7. Epub 2023 Mar 29.
[2] van Raaij, M.J., Mitraki, A., Lavigne, G., and Cusack, S. (1999). A triple beta-
spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous
protein. Nature 401, 935–938.
[3] Taylor, N.M., Prokhorov, N.S., Guerrero-Ferreira, R.C., Shneider, M.M.,
Browning, C., Goldie, K.N., Stahlberg, H., and Leiman, P.G. (2016). Structure
of the T4 baseplate and its function in triggering sheath contraction. Nature
533, 346–352.
[4]Jiang F, Li N, Wang X, Cheng J, Huang Y, Yang Y, Yang J, Cai B, Wang YP, Jin Q, Gao N. Cryo-EM Structure and Assembly of an Extracellular Contractile Injection System. Cell. 2019 Apr 4;177(2):370-383.e15. doi: 10.1016/j.cell.2019.02.020. Epub 2019 Mar 21.
[5]Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat Med. 2004 Jun;10(6):625-32. doi: 10.1038/nm1048. Epub 2004 May 9.